Trinity Biotech plc (TRIB)

Market Cap	7.57M
Revenue (ttm)	59.13M
Net Income (ttm)	-20.33M
Shares Out	9.47M
EPS (ttm)	-2.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,071
Open	0.781
Previous Close	0.761
Day's Range	0.751 - 0.820
52-Week Range	0.750 - 3.550
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About TRIB

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and o...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 380
• Stock Exchange: NASDAQ
• Ticker Symbol: TRIB
• Website: https://www.trinitybiotech.com

Financial Performance

In 2023, Trinity Biotech's revenue was $56.83 million, a decrease of -9.10% compared to the previous year's $62.52 million. Losses were -$24.02 million, -41.43% less than in 2022.